Relationship of cytokines and cytokine signaling to immunodeficiency disorders in the mouse

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 1, 1998, Pages 61-67

  Morawetz, R A ^a   Giese, N A ^a   Gabriele, L ^a   Rothman, P ^c   Horak, I ^d   Ozato, K ^b   Morse III, H C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

ICSBP; Immunodeficiency; Interferon; MAIDS

Indexed keywords

UNIDENTIFIED RETROVIRUS;

CYTOKINE; CYTOKINE RECEPTOR;

ANIMAL; DISEASE MODEL; IMMUNOLOGY; MOUSE; PHYSIOLOGY; RETROVIRUS INFECTION; REVIEW; RODENT DISEASE;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; MICE; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; RECEPTORS, CYTOKINE; RETROVIRIDAE INFECTIONS;

EID: 0031602851     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000100008     Document Type: Article

References (32)

1. Morse III HC, Chattopadhyay SK, Makino M, Fredrickson TN, Hügin AW & Hartley JW (1992). Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS, 6: 607-621 (Editorial).
2. Morse III HC, Giese N, Morawetz R, Tang Y, Gazzinelli R, Kim W-K, Chattopadhyay S & Hartley JW (1995). Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Seminars in Immunopathology, 17: 231-245.
3. Jolicoeur P (1991). Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB Journal, 5: 2398-2405.
4. Chattopadhyay SK, Sengupta DN, Fredrickson TN, Morse III HC & Hartley JW (1991). Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. Journal of Virology, 65: 4232-4241.
5. Aziz DC, Hanna Z & Jolicoeur P (1989). Severe immunodeficiency disease induced by a defective murine leukemia virus. Nature, 338: 505-508.
6. Huang M, Simard C & Jolicoeur P (1989). Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science, 246: 1614-1616.
7. Makino M, Morse III HC , Fredrickson TN & Hartley JW (1990). H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. Journal of Immunology, 144: 4347-4355.
8. Makino M, Davidson WF, Fredrickson TN, Hartley JW & Morse III HC (1991). Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice. Immunogenetics, 33: 345-351.
9. Makino M, Tang Y, Murphy DB, Fredrickson TN, Okada Y, Fujiwara M, Chattopadhyay SK, Mizuochi T, Komuro K, Morse III HC & Hartley JW (1994). Influence of H-2 class II antigens on the development of murine AIDS. Journal of Immunology, 152: 4157-4164.
10. + T cells in resistance to murine AIDS in A/J mice. Journal of Immunology, 149: 1702-1706.
11. gag regions are both necessary for the pathogenicity of the murine AIDS virus. Journal of Virology, 68: 5532-5537.
12. Huang M, Simard C, Kay DG & Jolicoeur P (1991). The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. Journal of Virology, 65: 6562-6571.
13. Kim WK, Tang Y, Kenny JJ, Longo DL & Morse III HC (1994). In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages. Journal of Virology, 68: 6767-6769.
14. Mosier DE, Yetter RA & Morse III HC (1987). Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). Journal of Experimental Medicine, 165: 1737-1742.
15. + T cells. Journal of Virology, 68: 5819-5824.
16. Makino M, Yoshimatsu K, Azuma M, Okada Y, Hitoshi Y, Yagita H, Takatsu K & Komuro K (1995). Rapid development of murine AIDS is dependent on signals provided by CD54 and CD11a. Journal of Immunology, 155: 974-981.
17. Green KA, Crassi KM, Laman JD, Schoneveld A, Strawbridge RR, Foy TM, Noelle RJ & Green WR (1996). Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/ 6 mice. Journal of Virology, 70: 2569-2575.
18. + subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. Journal of Immunology, 148: 182-188.
19. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL & Morse III HC (1992). Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunological Reviews, 127: 183-204.
20. Gazzinelli RT, Giese NA & Morse III HC (1984). In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). Journal of Experimental Medicine, 180: 2199-2208.
21. Kanagawa O, Vaupel BA, Gayama S, Koehler G & Kopf M (1993). Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science, 262: 240-242.
22. Morawetz RA, Doherty TM, Giese NA, Hartley JW, Müller W, Kühn R, Rajewsky K, Coffman R & Morse III HC (1994). Resistance to murine acquired immunodeficiency syndrome. Science, 265: 264-267.
23. Morawetz RA, Gabriele L, Rizzo LV, Noben-Trauth N, Kühn R, Rajewsky K, Müller W, Doherty TM, Finkelman F, Coffman RL & Morse III HC (1996). IL-4-independent immunoglobulin class switch to IgE in the mouse. Journal of Experimental Medicine, 184: 1651-1661.
24. Kaplan MH, Schindler U, Smiley ST & Grusby MJ (1996). Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity, 4: 313-319.
25. Klinken SP, Fredrickson TN, Hartley JW, Tetter RA & Morse III HC (1988). Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. Journal of Immunology, 140: 1123-1131.
26. Giese NA, Gazzinelli RT, Actor JK, Morawetz RA, Sarzotti M & Morse III HC (1996). Retrovirus-elicited interleukin-12 and tumour necrosis factor-α as inducers of interferon-γ-mediated pathology in mouse AIDS. Immunology, 87: 467-474.
27. Uehara S, Hitoshi Y, Numata F, Makino M, Howard M, Mizuochi T & Takatsu K (1994). An IFN-γ-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. International Immunology, 6: 1937-1947.
28. Pitha PM, Biegel D, Yetter RA & Morse III HC (1988). Abnormal regulation of IFN-α, -β, and -γ expression in MAIDS, a murine retrovirus-induced immunodeficiency syndrome. Journal of Immunology, 141: 3611-3616.
29. Heng JKM, Price P, Lai CM & Beilharz MW (1996). Alpha/beta interferons increase host resistance to murine AIDS. Journal of Virology, 70: 4517-4522.
30. Darnell Jr JE, Kerr IM & Stark GR (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264: 1415-1421.
31. Kanno Y, Kozak CA, Schindler C, Driggers PH, Ennist DL, Gleason SL, Darnell Jr JE & Ozato K (1993). The genomic structure of the murine ICSBP gene reveals the presence of the γ interferon-responsive element, to which an ISGF3α subunit (or similar) molecule binds. Molecular and Cellular Biology, 13: 3951-3963.
32. Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobelock K-P, Gabriele L, Waring J, Bachmann MF, Zinkernagel RM, Morse III HC, Ozato K & Horak I (1996). Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell, 87: 307-317.